MetLife Investment Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-67,978
| Closed | -$40.8K | – | 2860 |
|
|
2023
Q3 | $40.8K | Hold |
67,978
| – | – | ﹤0.01% | 2846 |
|
|
2023
Q2 | $88.4K | Hold |
67,978
| – | – | ﹤0.01% | 2747 |
|
|
2023
Q1 | $120K | Buy |
67,978
+12,905
| +23% | +$22.7K | ﹤0.01% | 2477 |
|
|
2022
Q4 | $173K | Sell |
55,073
-11,761
| -18% | -$36.9K | ﹤0.01% | 2337 |
|
|
2022
Q3 | $327K | Hold |
66,834
| – | – | ﹤0.01% | 1934 |
|
|
2022
Q2 | $277K | Buy |
66,834
+7,166
| +12% | +$29.7K | ﹤0.01% | 2076 |
|
|
2022
Q1 | $347K | Buy |
59,668
+15,097
| +34% | +$87.7K | ﹤0.01% | 2004 |
|
|
2021
Q4 | $334K | Hold |
44,571
| – | – | ﹤0.01% | 1739 |
|
|
2021
Q3 | $402K | Hold |
44,571
| – | – | ﹤0.01% | 1654 |
|
|
2021
Q2 | $534K | Hold |
44,571
| – | – | ﹤0.01% | 1533 |
|
|
2021
Q1 | $558K | Sell |
44,571
-8,357
| -16% | -$105K | 0.01% | 1461 |
|
|
2020
Q4 | $826K | Hold |
52,928
| – | – | 0.01% | 1220 |
|
|
2020
Q3 | $500K | Hold |
52,928
| – | – | 0.01% | 1368 |
|
|
2020
Q2 | $474K | Hold |
52,928
| – | – | 0.01% | 1407 |
|
|
2020
Q1 | $337K | Hold |
52,928
| – | – | ﹤0.01% | 1429 |
|
|
2019
Q4 | $443K | Hold |
52,928
| – | – | ﹤0.01% | 1533 |
|
|
2019
Q3 | $479K | Hold |
52,928
| – | – | 0.01% | 1442 |
|
|
2019
Q2 | $570K | Buy |
52,928
+5,771
| +12% | +$62.2K | 0.01% | 1401 |
|
|
2019
Q1 | $450K | Hold |
47,157
| – | – | ﹤0.01% | 1515 |
|
|
2018
Q4 | $541K | Hold |
47,157
| – | – | 0.01% | 1322 |
|
|
2018
Q3 | $799K | Hold |
47,157
| – | – | 0.01% | 1242 |
|
|
2018
Q2 | $670K | Buy |
47,157
+7,971
| +20% | +$113K | 0.01% | 1225 |
|
|
2018
Q1 | $745K | Hold |
39,186
| – | – | 0.01% | 1143 |
|
|
2017
Q4 | $643K | Buy |
+39,186
| New | +$643K | 0.01% | 1259 |
|